These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1616229)
1. Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ueno Y; Sohma T Ann Intern Med; 1992 Aug; 117(3):266-7. PubMed ID: 1616229 [No Abstract] [Full Text] [Related]
2. Recombinant interferon-alpha 2 antibodies in renal cell carcinoma. Delta-P Study Group. Prümmer O; Porzsolt F J Interferon Res; 1994 Aug; 14(4):193-5. PubMed ID: 7822873 [No Abstract] [Full Text] [Related]
3. Severe hyponatremia caused by hyperglycaemia due to interferon alpha therapy in advanced renal cell carcinoma. Soetekouw PM; Koopman M; Burger D; Tjan-Heijnen VC; De Mulder PH Acta Oncol; 2009; 48(1):154-6. PubMed ID: 19101828 [No Abstract] [Full Text] [Related]
4. Interferon alfa-2a tretinoin in patients with metastatic renal cell carcinoma: a pilot study. Paule B; Bonhomme-Faivre L; Rudant E; Ferrière F Am J Health Syst Pharm; 1997 Jan; 54(2):190-2. PubMed ID: 9117809 [No Abstract] [Full Text] [Related]
5. Two injections of interferon-alpha could trigger the development of rheumatoid arthritis. Funauchi M; Ohno M; Nozaki Y; Kinoshita K; Sugiyama M; Kanamaru A Clin Exp Rheumatol; 2002; 20(6):871. PubMed ID: 12508785 [No Abstract] [Full Text] [Related]